Cancer Research UK | Evaluate

Teon claims an adenosine pathway, but it’s not alone

AACR preview: a lung cancer showdown

February 17, 2017

Lyparza sets Parp inhibitors a new target

November 24, 2015

Astra gives as well as taking away

April 08, 2015

Therapy focus – Potential for progress in mesothelioma is on the horizon

January 23, 2015

Interview – UK CAR-T player enters in stealth mode

September 30, 2014

Ditched marketed drug gets second big pharma endorsement

April 02, 2014

Forma signs second Celgene deal and sets stage for exit

June 04, 2013

Asco – Little fanfare for GemVax and Merck KGaA setbacks

February 01, 2013

EP Vantage Interview – Immatics ponders cash call as data approaches

January 29, 2013

Anyara sounds the death knell for 5T4-targeted anticancers

Load More